中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
21期
68-69
,共2页
右美托咪啶%芬太尼%气管插管%心血管反应
右美託咪啶%芬太尼%氣管插管%心血管反應
우미탁미정%분태니%기관삽관%심혈관반응
Dexmedetomidine%Fentanyl%Endotracheal intubation%Cardiovascular reaction
目的:探究右美托咪啶预防气管插管过程中心血管反应的临床疗效。方法选取我院从2011年1月~2014年11月收治的全身麻醉下行择期手术患者100例作为研究对象,通过随机分组的方法进行分组,分为治疗组与对照组,每组患者50例。治疗组患者实施右美托咪啶静脉泵注,对照组患者实施生理盐水静脉泵注,推注芬太尼注射液。对比2组患者的临床疗效以及呛咳反应率的差异性。结果治疗组患者的呛咳反应率要比对照组患者的呛咳反应率小36%,差异具有统计学意义(P <0.05)。结论应用右美托咪啶预防气管插管所产生的心血管反应,具有显著临床疗效。
目的:探究右美託咪啶預防氣管插管過程中心血管反應的臨床療效。方法選取我院從2011年1月~2014年11月收治的全身痳醉下行擇期手術患者100例作為研究對象,通過隨機分組的方法進行分組,分為治療組與對照組,每組患者50例。治療組患者實施右美託咪啶靜脈泵註,對照組患者實施生理鹽水靜脈泵註,推註芬太尼註射液。對比2組患者的臨床療效以及嗆咳反應率的差異性。結果治療組患者的嗆咳反應率要比對照組患者的嗆咳反應率小36%,差異具有統計學意義(P <0.05)。結論應用右美託咪啶預防氣管插管所產生的心血管反應,具有顯著臨床療效。
목적:탐구우미탁미정예방기관삽관과정중심혈관반응적림상료효。방법선취아원종2011년1월~2014년11월수치적전신마취하행택기수술환자100례작위연구대상,통과수궤분조적방법진행분조,분위치료조여대조조,매조환자50례。치료조환자실시우미탁미정정맥빙주,대조조환자실시생리염수정맥빙주,추주분태니주사액。대비2조환자적림상료효이급창해반응솔적차이성。결과치료조환자적창해반응솔요비대조조환자적창해반응솔소36%,차이구유통계학의의(P <0.05)。결론응용우미탁미정예방기관삽관소산생적심혈관반응,구유현저림상료효。
Objective To explore dexmedetomidine prevent the clinical curative effect of endotracheal intubation process center vascular response. Methods Selected our hospital from January 2011 to November 2014 were treated 100 cases of patients with general anesthesia downlink undergoing elective surgery as the research object, by the method of randomized grouping, divided into the treatment group and control group, 50 cases in each group patients. Treatment group patients implement dexmedetomidine intravenous injection pump, the control group, normal saline intravenous injection pump for the injection of fentanyl injection. Comparing the clinical curative effect of two groups patients and choking cough response rate differences. Results The treatment group patients choking cough response rate to choking cough response rate is 36% smaller than the control group patients, statistically significant difference (P<0.05). Conclusion Application of dexmedetomidine prevent cardiovascular reaction produced by endotracheal intubation, has significant clinical efficacy.